BioXcel Therapeutics (BTAI) Revenue (2022 - 2026)
BioXcel Therapeutics' (BTAI) quarterly Revenue came in at $206000.0 in Q1 2026, up 22.62% year-on-year from $168000.0 in Q1 2025, and down 19.53% quarter-over-quarter from $256000.0 in Q4 2025.
BioXcel Therapeutics (BTAI) Revenue (2022 - 2026) Analysis & Trends
BioXcel Therapeutics' Revenue history runs 5 years deep, the most recent figure standing at $206000.0 for Q1 2026.
- On a quarterly basis, Revenue rose 22.62% year-over-year to $206000.0 in Q1 2026; TTM through Mar 2026 was $680000.0, a 63.28% decrease from a year earlier, with the FY2025 full-year figure at $642000.0, down 71.67% from the prior year.
- Revenue eased to $206000.0 in Q1 2026 per BTAI's latest filing, from $256000.0 in the prior quarter.
- Across five years, Revenue topped out at $1.1 million in Q2 2024 and bottomed at $98000.0 in Q3 2025.
- The 5-year median for Revenue is $238000.0 (2022), against an average of $324600.0.
- Across the five-year window, Revenue soared 182.52% in 2024 and sank 89.13% in 2025, its largest moves.
- Year by year, Revenue stood at $238000.0 in 2022, then surged by 57.98% to $376000.0 in 2023, then dropped by 2.66% to $366000.0 in 2024, then plunged by 30.05% to $256000.0 in 2025, then fell by 19.53% to $206000.0 in 2026.
- Per Business Quant, the three latest BTAI Revenue figures stand at $206000.0 (Q1 2026), $256000.0 (Q4 2025), and $98000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.98 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 2.26 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 6.98 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 781.50 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 3.51 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 814.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.37 Bn |
| 10 | BioXcel Therapeutics | 10.62 Mn | 10.62 Mn | -77,000.00 | 206,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 206,000.00 |
| Dec 31, 2025 | 256,000.00 |
| Sep 30, 2025 | 98,000.00 |
| Jun 30, 2025 | 120,000.00 |
| Mar 31, 2025 | 168,000.00 |
| Dec 31, 2024 | 366,000.00 |
| Sep 30, 2024 | 214,000.00 |
| Jun 30, 2024 | 1.10 Mn |
| Mar 31, 2024 | 582,000.00 |
| Dec 31, 2023 | 376,000.00 |
| Sep 30, 2023 | 341,000.00 |
| Jun 30, 2023 | 457,000.00 |
| Mar 31, 2023 | 206,000.00 |
| Dec 31, 2022 | 238,000.00 |
| Sep 30, 2022 | 137,000.00 |